Subtopic Deep Dive

Pentraxins in Tissue Remodeling
Research Guide

What is Pentraxins in Tissue Remodeling?

Pentraxins are a family of conserved pattern recognition proteins that regulate tissue remodeling by modulating extracellular matrix deposition, fibrosis, and wound healing in inflammatory diseases.

PTX3, a prototypical long pentraxin, influences collagen organization and metalloproteinase activity during tissue repair (Garlanda et al., 2018, 196 citations). Short pentraxins like CRP and SAP also contribute to matrix regulation in fibrosis models. Over 10 key papers since 2010 document these roles, with Du Clos (2013, 245 citations) providing the foundational structural overview.

Curated Papers

Key Challenges

Why It Matters

PTX3 limits excessive fibrosis in renal and pulmonary diseases by tuning inflammation and ECM remodeling, offering biomarker potential for antifibrotic therapies (Bottazzi et al., 2016, 176 citations; Garlanda et al., 2018). In cardiovascular contexts, elevated PTX3 correlates with matrix alterations post-injury, guiding prognostic models (Ristagno et al., 2019, 163 citations). These insights support targeted interventions in CKD progression, where inflammation drives scarring (Kadatane et al., 2023, 229 citations).

Key Research Challenges

Fibrosis Mechanism Specificity

Distinguishing PTX3's protective versus pathological roles in ECM regulation remains unclear across tissues. Garlanda et al. (2018) highlight context-dependent effects in repair and cancer, complicating therapeutic translation. Bottazzi et al. (2016) note variable outcomes in hepatic models.

Biomarker Validation in Humans

Translating PTX3 levels from mouse models to human fibrosis endpoints lacks large cohort validation. Ristagno et al. (2019) report cardiovascular correlations but urge prospective trials. Du Clos (2013) underscores evolutionary conservation gaps in clinical utility.

Interaction Network Mapping

Pentraxin crosstalk with complement and miRNAs in remodeling pathways needs systems-level analysis. Doni et al. (2019, 152 citations) link PTX3 to innate networks, while Abonnenc et al. (2013, 168 citations) implicate miRNAs in fibroblast ECM secretion.

Essential Papers

Pentraxins: Structure, Function, and Role in Inflammation

Terry W. Du Clos · 2013 · ISRN Inflammation · 245 citations

The pentraxins are an ancient family of proteins with a unique architecture found as far back in evolution as the Horseshoe crab. In humans the two members of this family are C-reactive protein and...

The Role of Inflammation in CKD

Saurav Kadatane, Matthew Satariano, M. Massey et al. · 2023 · Cells · 229 citations

Chronic kidney disease (CKD) affects many adults worldwide. Persistent low-grade inflammation is a substantial factor in its development and progression and has correlated with increased mortality ...

PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer

Cecília Garlanda, Barbara Bottazzi, Elena Magrini et al. · 2018 · Physiological Reviews · 196 citations

Innate immunity includes a cellular and a humoral arm. PTX3 is a fluid-phase pattern recognition molecule conserved in evolution which acts as a key component of humoral innate immunity in infectio...

The pentraxins PTX3 and SAP in innate immunity, regulation of inflammation and tissue remodelling

Barbara Bottazzi, Antonio Inforzato, Massimo Messa et al. · 2016 · Journal of Hepatology · 176 citations

Extracellular Matrix Secretion by Cardiac Fibroblasts

Mélanie Abonnenc, Adam Nabeebaccus, Ursula Mayr et al. · 2013 · Circulation Research · 168 citations

Rationale: MicroRNAs (miRNAs), in particular miR-29b and miR-30c, have been implicated as important regulators of cardiac fibrosis. Objective: To perform a proteomics comparison of miRNA effects on...

Pentraxin 3 in Cardiovascular Disease

Giuseppe Ristagno, Francesca Fumagalli, Barbara Bottazzi et al. · 2019 · Frontiers in Immunology · 163 citations

The long pentraxin PTX3 is a member of the pentraxin family produced locally by stromal and myeloid cells in response to proinflammatory signals and microbial moieties. The prototype of the pentrax...

The Long Pentraxin PTX3 as a Link Between Innate Immunity, Tissue Remodeling, and Cancer

Andrea Doni, Matteo Stravalaci, Antonio Inforzato et al. · 2019 · Frontiers in Immunology · 152 citations

The innate immune system comprises a cellular and a humoral arm. Humoral pattern recognition molecules include complement components, collectins, ficolins, and pentraxins. These molecules are invol...

Reading Guide

Foundational Papers

Start with Du Clos (2013, 245 citations) for pentraxin structure and inflammation basics, then Abonnenc et al. (2013, 168 citations) for ECM secretion mechanisms in fibroblasts.

Recent Advances

Study Garlanda et al. (2018, 196 citations) for PTX3 in repair, Ristagno et al. (2019, 163 citations) for cardiovascular biomarker data, and Kadatane et al. (2023, 229 citations) for CKD inflammation.

Core Methods

Key techniques include PTX3 knockout mice for remodeling assays (Bottazzi et al., 2016), proteomics for ECM profiling (Abonnenc et al., 2013), and pattern recognition binding studies (Doni et al., 2019).

How PapersFlow Helps You Research Pentraxins in Tissue Remodeling

Discover & Search

Research Agent uses citationGraph on Garlanda et al. (2018) to map 196+ citing works on PTX3 in remodeling, then exaSearch for 'PTX3 fibrosis extracellular matrix' to uncover 50+ related papers like Bottazzi et al. (2016). findSimilarPapers expands to SAP roles in hepatic tissue repair.

Analyze & Verify

Analysis Agent applies readPaperContent to extract PTX3-collagen interaction data from Bottazzi et al. (2016), then runPythonAnalysis with pandas to quantify fibrosis metrics across datasets, verified by CoVe chain-of-verification and GRADE scoring for evidence strength in CKD contexts (Kadatane et al., 2023).

Synthesize & Write

Synthesis Agent detects gaps in PTX3 antifibrotic trials via contradiction flagging across Garlanda (2018) and Ristagno (2019), then Writing Agent uses latexEditText, latexSyncCitations, and latexCompile to generate a review manuscript with exportMermaid diagrams of pentraxin-ECM pathways.

Use Cases

"Analyze PTX3 expression datasets from fibrosis papers for statistical trends"

Research Agent → searchPapers('PTX3 fibrosis dataset') → Analysis Agent → readPaperContent + runPythonAnalysis (pandas correlation on expression levels) → matplotlib plots of remodeling markers.

"Draft LaTeX figure on pentraxin signaling in wound healing"

Synthesis Agent → gap detection in Garlanda (2018) → Writing Agent → latexGenerateFigure + latexSyncCitations (Du Clos 2013) + latexCompile → PDF with PTX3 pathway diagram.

"Find code for PTX3 single-cell RNA-seq analysis in tissue repair"

Research Agent → paperExtractUrls (recent PTX3 papers) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable scRNA-seq pipeline for fibroblast clustering.

Automated Workflows

Deep Research workflow scans 50+ pentraxin papers via searchPapers → citationGraph → structured report on remodeling roles with GRADE scores. DeepScan applies 7-step CoVe to validate PTX3 biomarker claims in Ristagno (2019), checkpointing stats from Kadatane (2023). Theorizer generates hypotheses on PTX3-miRNA interactions from Abonnenc (2013) and Doni (2019).

Try Doxa for Pentraxins in Tissue Remodeling Research

Frequently Asked Questions

What defines pentraxins in tissue remodeling?

Pentraxins like PTX3 and SAP regulate ECM deposition and fibrosis via pattern recognition (Du Clos, 2013). PTX3 modulates collagen and metalloproteinases in repair (Garlanda et al., 2018).

What methods study pentraxin remodeling functions?

Mouse knockout models assess PTX3 in wound healing (Bottazzi et al., 2016). Proteomics and miRNA profiling reveal ECM secretion links (Abonnenc et al., 2013).

What are key papers on this topic?

Du Clos (2013, 245 citations) covers structure; Garlanda et al. (2018, 196 citations) details PTX3 in repair; Bottazzi et al. (2016, 176 citations) focuses on inflammation regulation.

What open problems exist?

Human validation of PTX3 as antifibrotic biomarker lacks trials (Ristagno et al., 2019). Tissue-specific signaling networks need mapping (Doni et al., 2019).